DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Wouters EF, Bredenbröker D, Teichmann P. et al.
Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus.
J Clin Endocrinol Metab 2012;
97: E1720-1725
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.